Our son Danny, at just 31 years of age, has already undergone two kidney transplants. Unfortunately, he now faces the daunting challenge of needing a third transplant. Due to being highly sensitized, with nearly a 100% antibody level, his chances of receiving a transplant by conventional means are slim to none. This is where Imlifidase, a groundbreaking drug currently under review by the U.S. Food and Drug Administration (FDA), comes into play.

Imlifidase has the potential to open doors for countless individuals just like Danny. Many people currently on the kidney transplant waiting list, as well as those who might find themselves there in the future, are highly sensitized and unable to receive a transplant through traditional methods. This drug works by drastically reducing antibody levels, creating an opportunity for a successful transplant without the fear of immediate or hyperacute antibody-mediated rejection.

According to the United Network for Organ Sharing (UNOS), there are over 93,000 people in the United States waiting for a kidney transplant. Many of these patients face prolonged suffering and a decreased quality of life while they wait for a suitable match. For those who are highly sensitized, the wait can often feel indefinite and overwhelming.

By approving Imlifidase, the FDA can bring hope to thousands on the waiting list, including those with high antibody levels, by providing a pathway to life-saving transplants. This drug has already shown promise in clinical trials and is a beacon of hope for patients and families who otherwise face limited options.

We urge stakeholders, medical professionals, and compassionate individuals to join our call to action in raising awareness and supporting the approval of Imlifidase. Doing so will significantly enhance the lives of people with severe sensitization, giving them a chance at a healthier, longer life.

Please stand with us to ensure the timely approval of Imlifidase by the FDA. Every signature brings us one step closer to making a life-changing difference for Danny and so many others. Sign this petition today and be part of a transformative change in kidney transplant medicine.